Clinical trialNCT00622843CompletedPhase 3Interventional

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

SponsorHenry M. Jackson Foundation for the Advancement of Military MedicineEnrollment275HIV InfectionsStreptococcus Pneumoniae

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Purpose: To study the immune response of the newly licensed pneumococcal conjugate vaccine (PCV) in comparison to the pneumococcal polysaccharide vaccine (PPV) to determine if a significantly better immunologic response to boosting can be elicited in patients previously vaccinated with PPV.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brian Agan, MD
Uniformed Services University of the Health Sciences
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Naval Medical Center San Diego
San Diego, California, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
Tripler Army Medical Center
Tripler AMC, Hawaii, United States
National Naval Medical Center
Bethesda, Maryland, United States
San Antonio Military Medical Center
Lackland Air Force Base, Texas, United States
Naval Medical Center Portsmouth
Portsmouth, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Pneumococcal conjugate vaccinePNEUMOCOCCAL POLYSACCHARIDE VACCINE

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2002
Primary completion: 31 Jul 2013
Completion: 31 Jul 2013
Last update posted: 8 Jun 2025
Registered enrollment: 275
Registry id: NCT00622843

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.